Cardiovascular Effects of Systemic Infections
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 7624
Special Issue Editors
Interests: endothelial dysfunction; cardiovascular risk factors; prevention; myocardial regeneration; heart failure; COVID-19; preeclampsia
Interests: fetal cardiac disease; coronavirus; cytomegalovirus; coxsackievirus; Toxoplasma gondii; flu viruses; HIV; rubella virus; Streptococcus; parvovirus B19; herpes virus
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Infectious diseases remain a major healthcare problem, and have a great impact on the cardiovascular system. In this context, there are major issues concerning implanted cardiac devices and cardiac valves. A wide range of patients have associated community-acquired or nosocomial infections. Once fixed on a valve surface, bacterial infections are difficult or even impossible to clear out, and have a high mortality rate, even with correctly conducted antibiotic therapy. It is important to aid the development of solutions for these patients, such as coatings and prosthetic materials that have antithrombotic and antimicrobial properties.
Moreover, infectious diseases in pregnancy continue to pose risks for both the mother and the fetus. This has recently resurfaced with the advent of the COVID-19 pandemic. This Special Issue aims to explore recent scientific advances in understanding the impact maternal infections can have during pregnancy on both maternal and fetal cardiovascular systems. Maternal immunological adaptations during pregnancy increase the vulnerability of maternal organs to infections. The placenta plays an important, yet not fully understood, role in relation to the possibility of fetal infection. Even less is known about how infections manifest during the fetal life, their effect on fetal cardiovascular physiology, what treatments should be used, and the potential long-term consequences. New drugs may be valuable for treating both the mother and the fetus. Vaccines given to the mother may offer protection against infections and protect the fetus and newborn in the first month of life.
This Special Issue aims to bring together researchers from the field of infectious diseases, maternal-fetal medicine and cardiovascular medicine. We welcome the submission of unpublished original studies, including fundamental and clinical research studies, observational and interventional studies, randomized controlled trials and reviews.
Dr. Roxana Mihaela Popescu
Dr. Anca Maria Panaitescu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- endocarditis
- prosthetic valves
- heart failure
- therapeutic options
- vaccines
- prevention
- consequences of pregnancy-related infections
- maternal cardiac disease
- COVID-19
- fetal cardiac defects
- fetal heart failure
- cytomegalovirus
- fetal cardiac disease
- coronavirus
- coxsackievirus
- Toxoplasma gondii
- flu virus
- HIV
- rubella virus
- Streptococcus
- parvovirus B19
- herpes virus
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.